• Nenhum resultado encontrado

Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity.

N/A
N/A
Protected

Academic year: 2017

Share "Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity."

Copied!
7
0
0

Texto

Loading

Imagem

Table 1. Clinical features and patient demographics.
Figure 1. Changes in Na + channel associated parameters post-oxaliplatin in motor axons
Figure 2A) in accordance with previous studies [14,15]. In accordance with these changes, RRP was significantly reduced (Pre: 3.960.1 ms; Post: 3.460.2 ms; P,.05)
Table 2. Sensitivity of excitability parameters to oxaliplatin treatment. Parameter Restingvalue  Post-oxaliplatinvalue Percentagedifference P value Motor axons Refractoriness (%) 35.768 75.5621 213% P,.05 Strength-duration time constant (ms) 0.3956.02 0.3
+2

Referências

Documentos relacionados

IV: intravenous; D: day; 5-FU: 5-fluorouracil; G: grade; FOLFOX: oxaliplatin, 5-fluorouracil and leucovorin; mFOLFOX: FOLFOX with different dosage; PO: per oris ; FAC:

A tabela 4.8 indica o número de plantas de alpista e respectivas alturas, 8 dias após começo da germinação, para os quatro tipos de sementes (0Gy, 50Gy, 100Gy e 200Gy). Indica também

A intervenção neste ultimo foi baseada na fisioterapia convencional 3x/semana, em sessões de 1 hora, durante 12 semanas, no entanto ao GE foi adicionado 25 minutos de treino

For instance, in a phase II trial the combination of 85 mg/m 2 oxaliplatin on days 1 and 15 plus 80 mg/m 2 irinotecan on days 1, 8, and 15, given every 4 weeks with or

É nesta mudança, abruptamente solicitada e muitas das vezes legislada, que nos vão impondo, neste contexto de sociedades sem emprego; a ordem para a flexibilização como

Another group of researchers evaluated the role of oral glutamine in 86 patients with metastatic colorectal cancer treated with oxaliplatin (85 mg/m² on days 1 and 15 of each

High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer. MicroRNA-18a attenuates DNA

In the present study, we investigated the effects of chronic treatment with fl uoxetine in rats treated with oxaliplatin and evaluated the possible quantitative alterations in